Christgau S - Search Results

1

Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting.

Qvist P, Christgau S, Pedersen BJ, Schlemmer A, Christiansen C. Qvist P, et al. Among authors: christgau s. Bone. 2002 Jul;31(1):57-61. doi: 10.1016/s8756-3282(02)00791-3. Bone. 2002. PMID: 12110413

2

Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy.

Christgau S, Bitsch-Jensen O, Hanover Bjarnason N, Gamwell Henriksen E, Qvist P, Alexandersen P, Bang Henriksen D. Christgau S, et al. Bone. 2000 May;26(5):505-11. doi: 10.1016/S8756-3282(00)00248-9. Bone. 2000. PMID: 10773591

3

Collagen type II C-telopeptide fragments as an index of cartilage degradation.

Christgau S, Garnero P, Fledelius C, Moniz C, Ensig M, Gineyts E, Rosenquist C, Qvist P. Christgau S, et al. Bone. 2001 Sep;29(3):209-15. doi: 10.1016/s8756-3282(01)00504-x. Bone. 2001. PMID: 11557363

4

Mechanism of circadian variation in bone resorption.

Bjarnason NH, Henriksen EE, Alexandersen P, Christgau S, Henriksen DB, Christiansen C. Bjarnason NH, et al. Among authors: christgau s. Bone. 2002 Jan;30(1):307-13. doi: 10.1016/s8756-3282(01)00662-7. Bone. 2002. PMID: 11792602 Clinical Trial.

5

An immunoassay for measuring fragments of newly synthesized collagen type I produced during metastatic invasion of bone.

Cloos PA, Lyubimova N, Solberg H, Qvist P, Christiansen C, Byrjalsen I, Christgau S. Cloos PA, et al. Among authors: christgau s. Clin Lab. 2004;50(5-6):279-89. Clin Lab. 2004. PMID: 15209436

6

The effect on cartilage of different forms of application of postmenopausal estrogen therapy: comparison of oral and transdermal therapy.

Ravn P, Warming L, Christgau S, Christiansen C. Ravn P, et al. Among authors: christgau s. Bone. 2004 Nov;35(5):1216-21. doi: 10.1016/j.bone.2004.07.017. Bone. 2004. PMID: 15542048 Clinical Trial.

7

Breast cancer patients with bone metastases are characterised by increased levels of nonisomerised type I collagen fragments.

Cloos PA, Christgau S, Lyubimova N, Body JJ, Qvist P, Christiansen C. Cloos PA, et al. Among authors: christgau s. Breast Cancer Res. 2003;5(4):R103-9. doi: 10.1186/bcr607. Epub 2003 May 19. Breast Cancer Res. 2003. PMID: 12818000 Free PMC article.

8

Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen.

Rosenquist C, Fledelius C, Christgau S, Pedersen BJ, Bonde M, Qvist P, Christiansen C. Rosenquist C, et al. Among authors: christgau s. Clin Chem. 1998 Nov;44(11):2281-9. Clin Chem. 1998. PMID: 9799755 Clinical Trial.

9

Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides.

Christgau S, Rosenquist C, Alexandersen P, Bjarnason NH, Ravn P, Fledelius C, Herling C, Qvist P, Christiansen C. Christgau S, et al. Clin Chem. 1998 Nov;44(11):2290-300. Clin Chem. 1998. PMID: 9799756 Clinical Trial.

10

Effect of bisphosphonates on cartilage turnover assessed with a newly developed assay for collagen type II degradation products.

Lehmann HJ, Mouritzen U, Christgau S, Cloos PA, Christiansen C. Lehmann HJ, et al. Among authors: christgau s. Ann Rheum Dis. 2002 Jun;61(6):530-3. doi: 10.1136/ard.61.6.530. Ann Rheum Dis. 2002. PMID: 12006327 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters